News
News
Services
TRANSVAC2 offers a wide range of services, the majority of which can be accessed free-of-charge. These services range from shorter services lasting a few weeks, to longer services lasting several months. All of the available services and the institutions involved are summarised below.
Vaccine R&D Pipeline
Antigen discovery
Formulation
Animal
studies
Process
Development
cGMP
Manufacture
Industrial
Scale-up
Pre-licensure
Clinical Trials
Licensure
Post-licensure
Clinical Trials
Platforms
TRANSVAC’s services are organised in four different platforms: Technology, Immunocorrelates and System Biology, Animal Models and Clinical Trial and Regulatory Support. Applicants are encouraged to follow an integrated approach by applying for complementing services. Suggestions for complementing services are shown in the overview diagram and under the individual services.
Technology
Immunocorrelates & System Biology
Animal Models
Services at all stages
of the Vaccine R&D Pipeline
OPEN CALL for SERVICES
Submit your application for Vaccine Development Services
TRANSVAC2 TNA CALL FOR PROPOSALS
With the pandemic still ongoing, TRANSVAC2 is renewing its commitment to supporting academic and commercial vaccine developers through a new call for proposals dedicated to SARS-CoV-2 / COVID-19, with a special emphasis on variants of concern. Other project proposals will also be considered.
You may apply for free-of-charge TNA vaccine development services to advance your research in one of the following main areas:
Technology
Antigen screening, optimization, expression, and production
Adjuvant formulation and characterization (incl. liposomal, mucosal, and parenteral adjuvants)
Analytical services offer diverse structural and cellular assays (Now including Luminex potency assay!)
GLP/GMP vaccine production using bacterial, yeast, plant, insect, and mammalian platforms
Immunocorrelates/ systems biology
Includes sequencing, cytometry and various -omics services
Statistical analysis and mathematical modelling
Animal models
Services offer a wide range of species and validated disease models, from rodents to NHPs
Clinical trial and regulatory support services
We highly encourage all applicants to request regulatory support alongside scientific technical services, as early assessment of regulatory requirements may prevent unnecessary project delays, reduce costs and ensure adherence to legal requirements.
Service availability is dependent on budgetary, and timeline constrains and thus subject to change at later stages of the application process. Applicants should contact service providers before submission.
DEADLINE
This call for proposals will remain open until May 31st, 2022. Your proposal will be evaluated, selected and implemented according to the selection process.
APPLICATION
Applicants can be affiliated to an organization (public or private) located in the EU, an associated country or any other country. For more information about TRANSVAC2 TNA Programme, including the conditions for access & eligibility, please refer to Apply now.
To apply, please make sure that you use the latest TNA Application Form linked and carefully read the form and help text.
Please note that an organization can submit several applications led by different Users.
For any further question, please contact TRANSVAC2 Coordinating team (transvacinfo@euvaccine.eu).